In 2010 Biotie Therapies acquired Elbion GmbH, a German pharmaceutical company in Radebeul, a suburb of Dresden.
In 2010 Biotie Therapies all preclinical assets were transferred into a new company, biocrea GmbH, in which Biotie become a minority shareholder. 
